article thumbnail

Bold moves in global M&A might appear in 2023

Future CFO

Bold moves in global M&A might appear in 2023 — a year full of uncertainties, said Bain & Company recently when releasing its 5th annual Global Mergers & Acquisitions Report. The largest drops came among deals for Technology and Healthcare & Life Sciences assets, the firm pointed out.

article thumbnail

NowRX CEO: Why DTC Pharmacy Is An Easier Pill For Consumers To Swallow

PYMNTS

Pointing to Walgreens ’ pact with VillageMD , NowRX Co-Founder and CEO Cary Breese told PYMNTS CEO Karen Webster, “There’s an entirely new dimension to delivery pharmacy and healthcare. It’s core to their profitability, and I think they’re misaligned,” he said. “It’s That’s a better model.”.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transcript: Michael Fisch

Barry Ritholtz

They’re one of the older private equity firms around, been been in business since 1994. They run over $27 billion in, in assets. Then I think you’re gonna find this to be a fascinating conversation. 00:01:24 [Michael Fisch] Thank you Barry. It’s a pleasure to be here. You get a Stanford MBA. What was the original career plan?

article thumbnail

Transcript: Steven Klinsky

Barry Ritholtz

KLINSKY: I’m a big fan of both of them and a big fan of the JD/MBA program and involved with both schools still today. I’m a big fan of multidisciplinary approaches. He eventually goes to a Forstmann Little where he’s one of the first five founding partners. They grew a business where they issued junk debt.